Recursion Pharma , which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths in the colon in patients with a rare ...
Shares of Recursion Pharmaceuticals are trading higher Monday after the company reported positive data from an ongoing trial.
In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...
InvestorsHub on MSN
Recursion Pharmaceuticals rises 7% after reporting strong mid-stage data in FAP study
Recursion Pharmaceuticals (NASDAQ:RXRX) gained 7% on Monday after releasing encouraging Phase 2 results for REC-4881, its ...
Valerie is a seasoned writer and editor who has spent her career creating content in the parenting and women's wellness spaces. Before joining Forbes Health, Valerie was the trending news editor at ...
Saudi Arabian Grand Prix: 1st: Piastri, 2nd: Verstappen, 3rd: Leclerc Miami Grand Prix: 1st: Piastri, 2nd: Norris, 3rd: Russell Emilia Romagna Grand Prix: 1st ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results